Terlipressin infusion in Living Donor Liver Transplantatio

Not Applicable

• Conditions: Digestive System; Surgery; End-stage liver disease going for liver transplantation

• Registration Number: PACTR201402000752252
• Lead Sponsor: ational Liver Institute, Menoufiya University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-28
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Model for end stage liver disease (MELD) between 12 and 20.

Exclusion Criteria

Systemic vascular resistance index (SVRI) ¿ 1700 dyne·s/cm5/m2
History of myocardial infarction.
Evidence of cardiac decompensation.
Severe haemodynamic instability.
Primary renal dysfunction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified